Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
261.28
215.39
243.78
239.46
200.49
184.73
201.27
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
261.28
215.39
243.78
239.46
200.49
184.73
201.27
Raw Material Cost
69.16
50.47
74.51
65.61
44.11
37.95
60.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.07
3.23
3.55
3.62
3.65
3.84
4.21
Selling and Distribution Expenses
56.21
58.24
80.78
53.40
58.04
55.99
50.50
Other Expenses
4.35
6.61
4.64
5.13
4.65
3.07
3.05
Total Expenditure (Excl Depreciation)
171.96
178.10
205.22
173.97
152.31
128.49
145.54
Operating Profit (PBDIT) excl Other Income
89.3
37.3
38.6
65.5
48.2
56.2
55.7
Other Income
7.02
5.63
5.75
5.62
5.10
4.77
4.64
Operating Profit (PBDIT)
102.30
48.89
51.74
77.08
59.25
66.98
66.33
Interest
3.07
3.23
3.55
3.62
3.65
3.84
4.21
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
192.12
164.91
169.27
173.84
156.38
146.78
140.90
Depreciation
5.97
5.97
7.43
5.97
5.97
5.97
5.97
Profit Before Tax
93.27
39.69
40.76
67.49
49.64
57.18
56.16
Tax
17.83
7.20
18.27
16.62
9.86
11.62
6.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
75.43
32.49
22.49
50.87
39.78
45.56
49.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
75.43
32.49
22.49
50.87
39.78
45.56
49.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
75.43
32.49
22.49
50.87
39.78
45.56
49.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
999.24
910.35
870.22
835.12
773.08
720.52
659.15
Earnings per share (EPS)
1.28
0.55
0.38
0.87
0.68
0.78
0.85
Diluted Earnings per share
1.28
0.55
0.38
0.87
0.68
0.78
0.85
Operating Profit Margin (Excl OI)
34.18%
17.31%
15.82%
27.35%
24.03%
30.45%
27.69%
Gross Profit Margin
37.98%
21.2%
19.77%
30.68%
27.73%
34.18%
30.87%
PAT Margin
28.87%
15.08%
9.22%
21.24%
19.84%
24.66%
24.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 30.32% vs 16.03% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 89.45% vs 243.10% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 76.16% vs 97.45% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -13.89% vs -18.18% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Harmony Biosciences Holdings, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
261.28
0.00
261.28
Other Operating Income
0.00
0.00
0.00
Total Operating income
261.28
0.00
261.28
Raw Material Cost
69.16
0.59
68.57
11,622.03%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
45.90
-45.90
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
3.07
0.00
3.07
Selling and Distribution Expenses
56.21
23.82
32.39
135.98%
Other Expenses
4.35
4.20
0.15
3.57%
Total Expenditure (Excl Depreciation)
171.96
112.33
59.63
53.08%
Operating Profit (PBDIT) excl Other Income
89.32
-112.33
201.65
179.52%
Other Income
7.02
7.46
-0.44
-5.90%
Operating Profit (PBDIT)
102.30
-104.29
206.59
198.09%
Interest
3.07
0.00
3.07
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
192.12
-0.59
192.71
32,662.71%
Depreciation
5.97
0.59
5.38
911.86%
Profit Before Tax
93.27
-104.87
198.14
188.94%
Tax
17.83
-2.57
20.40
793.77%
Provisions and contingencies
0
0
0.00
Profit After Tax
75.43
-102.30
177.73
173.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
75.43
-102.30
177.73
173.73%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
75.43
-102.30
177.73
173.73%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
999.24
1,337.82
-338.58
-25.31%
Earnings per share (EPS)
1.28
-1.17
2.45
209.40%
Diluted Earnings per share
1.28
-1.17
2.45
209.40%
Operating Profit Margin (Excl OI)
34.18%
0.00%
0.00
34.18%
Gross Profit Margin
37.98%
0.00%
0.00
37.98%
PAT Margin
28.87%
0.00%
0.00
28.87%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.13 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 21.31% vs -11.65% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 30.32% vs 16.03% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 7.54 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 132.00% vs 44.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 89.45% vs 243.10% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.53 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 120.09% vs -5.87% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 76.16% vs 97.45% in Jun 2025
Quarterly - Interest
Interest 0.31 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -3.13% vs -8.57% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -13.89% vs -18.18% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.18%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
